Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tanzania | 31 | 2023 | 1387 | 1.620 |
Why?
|
AIDS Vaccines | 12 | 2022 | 896 | 1.580 |
Why?
|
Tuberculosis | 10 | 2022 | 2017 | 1.530 |
Why?
|
Vaccines, DNA | 6 | 2020 | 286 | 1.110 |
Why?
|
HIV Infections | 20 | 2023 | 17352 | 0.740 |
Why?
|
Viral Vaccines | 4 | 2020 | 596 | 0.650 |
Why?
|
Tuberculosis, Pulmonary | 2 | 2022 | 832 | 0.580 |
Why?
|
Mycobacterium tuberculosis | 4 | 2022 | 1914 | 0.540 |
Why?
|
Immunization, Secondary | 5 | 2020 | 367 | 0.500 |
Why?
|
Police | 2 | 2013 | 157 | 0.470 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5841 | 0.410 |
Why?
|
Voluntary Programs | 1 | 2010 | 48 | 0.360 |
Why?
|
Bacteremia | 2 | 2020 | 980 | 0.340 |
Why?
|
AIDS Serodiagnosis | 1 | 2010 | 220 | 0.320 |
Why?
|
Stroke | 5 | 2023 | 9758 | 0.310 |
Why?
|
Sputum | 3 | 2019 | 506 | 0.290 |
Why?
|
HIV-1 | 7 | 2023 | 6863 | 0.280 |
Why?
|
Anti-HIV Agents | 1 | 2022 | 4527 | 0.260 |
Why?
|
Mass Screening | 1 | 2019 | 5428 | 0.220 |
Why?
|
Fever | 1 | 2011 | 1618 | 0.220 |
Why?
|
Tuberculin Test | 2 | 2022 | 206 | 0.220 |
Why?
|
Counseling | 1 | 2010 | 1547 | 0.200 |
Why?
|
Tuberculosis Vaccines | 1 | 2022 | 48 | 0.200 |
Why?
|
Circumcision, Male | 2 | 2012 | 148 | 0.180 |
Why?
|
Lipid A | 2 | 2018 | 70 | 0.170 |
Why?
|
Lymphocyte Count | 1 | 2022 | 778 | 0.170 |
Why?
|
Pregnancy, Unplanned | 1 | 2020 | 85 | 0.170 |
Why?
|
Syphilis | 1 | 2022 | 243 | 0.170 |
Why?
|
Blood Cell Count | 1 | 2020 | 397 | 0.170 |
Why?
|
Proteinuria | 1 | 2022 | 607 | 0.160 |
Why?
|
Isoniazid | 1 | 2020 | 283 | 0.160 |
Why?
|
Respiratory Sounds | 1 | 2022 | 702 | 0.150 |
Why?
|
HIV Envelope Protein gp41 | 1 | 2020 | 303 | 0.150 |
Why?
|
Prevalence | 6 | 2022 | 15732 | 0.150 |
Why?
|
Hospital Mortality | 2 | 2023 | 5293 | 0.150 |
Why?
|
BCG Vaccine | 1 | 2020 | 369 | 0.150 |
Why?
|
Epitopes | 2 | 2023 | 2503 | 0.140 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 2 | 2018 | 369 | 0.140 |
Why?
|
Prospective Studies | 9 | 2023 | 54426 | 0.140 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 1 | 2017 | 206 | 0.140 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2021 | 851 | 0.130 |
Why?
|
CD4 Lymphocyte Count | 1 | 2022 | 2571 | 0.130 |
Why?
|
Medical History Taking | 1 | 2019 | 774 | 0.130 |
Why?
|
HIV Antibodies | 5 | 2023 | 1303 | 0.130 |
Why?
|
Hospitals, Teaching | 1 | 2020 | 1156 | 0.130 |
Why?
|
Anti-Retroviral Agents | 2 | 2022 | 1784 | 0.120 |
Why?
|
Glucosides | 2 | 2018 | 512 | 0.120 |
Why?
|
Adult | 20 | 2023 | 221203 | 0.120 |
Why?
|
Vaccination | 4 | 2023 | 3384 | 0.110 |
Why?
|
HIV Seropositivity | 1 | 2019 | 960 | 0.110 |
Why?
|
Female | 25 | 2023 | 392686 | 0.110 |
Why?
|
Immunoglobulin G | 3 | 2023 | 4544 | 0.110 |
Why?
|
Male | 23 | 2023 | 360842 | 0.110 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2022 | 1897 | 0.110 |
Why?
|
Humans | 34 | 2023 | 761572 | 0.110 |
Why?
|
Perception | 1 | 2019 | 1197 | 0.110 |
Why?
|
Viral Load | 1 | 2022 | 3332 | 0.110 |
Why?
|
Mortality | 2 | 2021 | 2901 | 0.100 |
Why?
|
Lymphocytes | 1 | 2020 | 2612 | 0.100 |
Why?
|
Immunization Schedule | 3 | 2020 | 227 | 0.100 |
Why?
|
HIV | 1 | 2019 | 1582 | 0.100 |
Why?
|
Hepatitis C | 1 | 2022 | 1584 | 0.100 |
Why?
|
Cohort Studies | 3 | 2022 | 41493 | 0.100 |
Why?
|
Antitubercular Agents | 1 | 2020 | 1375 | 0.100 |
Why?
|
Adaptive Immunity | 1 | 2017 | 726 | 0.100 |
Why?
|
Vaccinia virus | 3 | 2018 | 331 | 0.100 |
Why?
|
Patient Dropouts | 1 | 2013 | 412 | 0.090 |
Why?
|
Monocytes | 1 | 2020 | 2570 | 0.090 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 26127 | 0.090 |
Why?
|
Immunity, Humoral | 1 | 2015 | 606 | 0.090 |
Why?
|
Adjuvants, Immunologic | 1 | 2016 | 1036 | 0.090 |
Why?
|
Bacteriological Techniques | 1 | 2011 | 275 | 0.090 |
Why?
|
Young Adult | 10 | 2021 | 59255 | 0.080 |
Why?
|
Middle Aged | 15 | 2023 | 220920 | 0.080 |
Why?
|
Blood Platelets | 1 | 2020 | 2479 | 0.080 |
Why?
|
T-Lymphocytes | 2 | 2017 | 10194 | 0.080 |
Why?
|
Blood | 1 | 2011 | 596 | 0.080 |
Why?
|
DNA, Viral | 1 | 2015 | 2202 | 0.080 |
Why?
|
Public Opinion | 1 | 2012 | 484 | 0.070 |
Why?
|
Pneumonia | 1 | 2019 | 2143 | 0.070 |
Why?
|
Neutrophils | 1 | 2020 | 3767 | 0.070 |
Why?
|
Registries | 1 | 2023 | 8224 | 0.070 |
Why?
|
Adolescent | 8 | 2022 | 88324 | 0.070 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2010 | 662 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3810 | 0.070 |
Why?
|
Blotting, Western | 1 | 2013 | 5035 | 0.060 |
Why?
|
Length of Stay | 1 | 2019 | 6426 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2023 | 58986 | 0.060 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 2 | 2017 | 303 | 0.060 |
Why?
|
Hypertension | 2 | 2023 | 8540 | 0.060 |
Why?
|
Blood Glucose | 1 | 2019 | 6391 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 4016 | 0.060 |
Why?
|
Logistic Models | 1 | 2019 | 13255 | 0.060 |
Why?
|
Risk Factors | 6 | 2023 | 74213 | 0.060 |
Why?
|
Vaccines, Synthetic | 2 | 2017 | 616 | 0.060 |
Why?
|
Antibodies, Neutralizing | 3 | 2020 | 1943 | 0.060 |
Why?
|
Body Mass Index | 1 | 2022 | 12954 | 0.060 |
Why?
|
Lipopolysaccharides | 1 | 2012 | 2206 | 0.060 |
Why?
|
Interferon-gamma | 3 | 2017 | 3162 | 0.060 |
Why?
|
Sexual Partners | 2 | 2022 | 796 | 0.060 |
Why?
|
Incidence | 3 | 2022 | 21355 | 0.060 |
Why?
|
Sexual Behavior | 1 | 2014 | 2180 | 0.060 |
Why?
|
Lung | 1 | 2022 | 10002 | 0.060 |
Why?
|
Attitude to Health | 1 | 2012 | 2025 | 0.050 |
Why?
|
Qualitative Research | 3 | 2020 | 3023 | 0.050 |
Why?
|
Drug Carriers | 2 | 2017 | 706 | 0.050 |
Why?
|
Patient Selection | 1 | 2013 | 4244 | 0.050 |
Why?
|
Urban Population | 2 | 2023 | 2036 | 0.050 |
Why?
|
Aged | 6 | 2023 | 169310 | 0.040 |
Why?
|
Mozambique | 1 | 2018 | 55 | 0.040 |
Why?
|
Cross Reactions | 1 | 2020 | 817 | 0.040 |
Why?
|
Hospitalization | 2 | 2020 | 10721 | 0.040 |
Why?
|
Electroporation | 1 | 2018 | 255 | 0.040 |
Why?
|
Family Characteristics | 1 | 2022 | 1004 | 0.040 |
Why?
|
Vaccines, Subunit | 1 | 2017 | 161 | 0.040 |
Why?
|
Administration, Cutaneous | 1 | 2018 | 713 | 0.030 |
Why?
|
HIV Envelope Protein gp120 | 1 | 2020 | 914 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3306 | 0.030 |
Why?
|
Ambulatory Care Facilities | 1 | 2020 | 935 | 0.030 |
Why?
|
Neutralization Tests | 1 | 2016 | 728 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2021 | 1267 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15501 | 0.030 |
Why?
|
Phylogeny | 1 | 2020 | 2811 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2017 | 1889 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6484 | 0.020 |
Why?
|
Patient Compliance | 1 | 2020 | 2690 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2017 | 1802 | 0.020 |
Why?
|
Echocardiography | 1 | 2021 | 4989 | 0.020 |
Why?
|
Medication Adherence | 1 | 2020 | 2176 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2021 | 3879 | 0.020 |
Why?
|
Caregivers | 1 | 2020 | 2238 | 0.020 |
Why?
|
Electrocardiography | 1 | 2021 | 6377 | 0.020 |
Why?
|
Risk-Taking | 1 | 2014 | 1038 | 0.020 |
Why?
|
Child | 2 | 2020 | 80156 | 0.020 |
Why?
|
Time Factors | 2 | 2021 | 39970 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2020 | 5112 | 0.020 |
Why?
|
Social Stigma | 1 | 2014 | 769 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7827 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29629 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2017 | 4352 | 0.020 |
Why?
|
Blood Pressure | 1 | 2021 | 8481 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 5485 | 0.020 |
Why?
|
ROC Curve | 1 | 2012 | 3579 | 0.010 |
Why?
|
Age Factors | 1 | 2021 | 18398 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2020 | 64684 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 23996 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 29876 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36192 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42230 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2012 | 5336 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39107 | 0.010 |
Why?
|
Concepts
(151)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_